Rhythm Pharmaceuticals (RYTM) Shareholder's Equity (2016 - 2026)

Rhythm Pharmaceuticals (RYTM) Shareholder's Equity (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 7.14 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 595,226.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - 502.95 Mn
10 Rhythm Pharmaceuticals 6.59 Bn 6.25 Bn 52.96 Mn 122.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 122.91 Mn
Dec 31, 2025 139.07 Mn
Sep 30, 2025 148.82 Mn
Jun 30, 2025 -11.91 Mn
Mar 31, 2025 18.95 Mn
Dec 31, 2024 21.73 Mn
Sep 30, 2024 11.22 Mn
Jun 30, 2024 39.34 Mn
Mar 31, 2024 61.58 Mn
Dec 31, 2023 169.76 Mn
Sep 30, 2023 197.47 Mn
Jun 30, 2023 182.29 Mn
Mar 31, 2023 219.76 Mn
Dec 31, 2022 264.26 Mn
Sep 30, 2022 281.20 Mn
Jun 30, 2022 195.63 Mn
Mar 31, 2022 235.77 Mn
Dec 31, 2021 284.15 Mn
Sep 30, 2021 322.26 Mn
Jun 30, 2021 351.69 Mn